Skip to main content

Table 2 Biotesting systems used

From: Microfinance for women at high risk for HIV in Kazakhstan: study protocol for a cluster-randomized controlled trial

Infection

Testing specimen

Test system used

Sensitivity (95% CIa)

Specificity (95% CIa)

HIV

Finger stick (whole blood sample)

Alere Determineâ„¢ HIV-1/2 Ag/Ab Combo rapid test system [47]

99.9% (99.4–100.0%)

99.8% (99.5–99.9%)

Hepatitis C (HCV)

Dried blood spot

Murex anti-HCV (version 4.0) [48]

100% (94.79-100%)

99.88% (99.77–99.94%)

Syphilis

Dried blood spot

Murex ICE Syphilis [49]

100% (99.1–100%)

100% (99.2–100%)

Gonorrhea

Vaginal specimen

AmpliSense N. gonorrhea/C. trahomatis/M. genitalium/T. vaginalis-MULTIPRIME-FRT PCR [50]

N/Ab

N/Ab

Trichomoniasis

Vaginal specimen

AmpliSense N. gonorrhea/C. trahomatis/M. genitalium/T. vaginalis-MULTIPRIME-FRT PCR [50]

N/Ab

N/Ab

Chlamydia

Vaginal specimen

AmpliSense N. gonorrhea/C. trahomatis/M. genitalium/T. vaginalis-MULTIPRIME-FRT PCR [50]

100% (73.3–100%)

100% (98.1–- 100%)

Mycoplasma genitalium

Vaginal specimen

AmpliSense N. gonorrhea/C. trahomatis/M. genitalium/T. vaginalis-MULTIPRIME-FRT PCR [50]

76.5% (50.1–93.0%)

100% (98.1–100%)

  1. aCI confidence interval
  2. bN/A estimates are not available for vaginal specimen samples